when was semaglutide discovered protects heart beyond weight loss benefits how was semaglutide discovered Therapeutic

The approach differs meaningfully depending on whether the patient can tolerate oral fluids

About the SELECT Trial 7 SELECT was a randomized, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to standard of care for prevention of major adverse cardiovascular outcomes (MACE) in people with established cardiovascular disease with overweight or obesity with no prior history of diabetes

Since semaglutide is often prescribed for diabetes management or weight loss, excessive drinking may counteract its intended effects

In the fasting state, GH increases lipolysis and hepatic glucose output while insulin concentration decreases (Rabinowitz et al., 1965)